Jacobson Pharma Corporation Limited
HKEX:2633.HK
0.75 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | 2013 Q4 | 2013 Q3 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 752.88 | 714.918 | 968.226 | 817.353 | 845.13 | 750.413 | 750.49 | 695.425 | 699.773 | 871.686 | 816.26 | 805.652 | 743.032 | 680.508 | 575.449 | 565.674 | 518.182 | 236.898 | 236.898 | 231.545 | 231.545 | 231.545 | 231.545 |
Cost of Revenue
| 433.484 | 413.839 | 561.483 | 476.924 | 497.45 | 477.571 | 455.664 | 429.168 | 368.312 | 513.169 | 497.566 | 466.894 | 464.128 | 368.232 | 330.837 | 298.349 | 297.752 | 140.721 | 140.721 | 125.335 | 125.335 | 125.335 | 125.335 |
Gross Profit
| 319.396 | 301.079 | 406.743 | 340.429 | 347.68 | 272.842 | 294.826 | 266.257 | 331.461 | 358.517 | 318.694 | 338.758 | 278.904 | 312.276 | 244.612 | 267.325 | 220.43 | 96.177 | 96.177 | 106.211 | 106.211 | 106.211 | 106.211 |
Gross Profit Ratio
| 0.424 | 0.421 | 0.42 | 0.417 | 0.411 | 0.364 | 0.393 | 0.383 | 0.474 | 0.411 | 0.39 | 0.42 | 0.375 | 0.459 | 0.425 | 0.473 | 0.425 | 0.406 | 0.406 | 0.459 | 0.459 | 0.459 | 0.459 |
Reseach & Development Expenses
| 6.45 | 0 | 2.121 | 0 | 7.591 | 0 | 0 | 0 | 0 | 0 | 0 | 1.906 | 4.234 | 6.091 | 0.251 | 3.964 | 1.673 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 105.867 | 97.82 | 135.085 | 77.926 | 119.568 | 93.978 | 0 | 98.749 | 0 | 97.073 | 82.297 | 86.213 | 85.94 | 60.772 | 97.869 | 85.632 | 73.405 | 62.968 | 62.968 | 66.774 | 66.774 | 66.774 | 66.774 |
Selling & Marketing Expenses
| 63.915 | 64.775 | 104.641 | 54.392 | 95.496 | 88.591 | 0 | 91.73 | 0 | 92.203 | 83.233 | 83.113 | 83.962 | 72.749 | 72.601 | 65.483 | 68.324 | -0.46 | -0.46 | -0.455 | -0.455 | -0.455 | -0.455 |
SG&A
| 169.782 | 162.595 | 239.726 | 188.344 | 215.064 | 182.569 | 192.142 | 183.437 | 200.005 | 194.936 | 165.53 | 169.326 | 169.902 | 133.521 | 170.47 | 151.115 | 141.729 | 62.508 | 62.508 | 66.32 | 66.32 | 66.32 | 66.32 |
Other Expenses
| -23.989 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 152.243 | 162.595 | 239.726 | 188.344 | 215.064 | 182.569 | 192.142 | 183.437 | 200.005 | 194.936 | 159.496 | 158.15 | 166.231 | 155.439 | 167.926 | 164.642 | 140.77 | 62.508 | 62.508 | 66.32 | 66.32 | 66.32 | 66.32 |
Operating Income
| 167.153 | 138.484 | 167.017 | 152.085 | 132.616 | 90.273 | 102.684 | 82.82 | 131.456 | 163.581 | 154.429 | 170.261 | 109.848 | 179.752 | 74.434 | 116.854 | 79.103 | 33.669 | 33.669 | 39.891 | 39.891 | 39.891 | 39.891 |
Operating Income Ratio
| 0.222 | 0.194 | 0.172 | 0.186 | 0.157 | 0.12 | 0.137 | 0.119 | 0.188 | 0.188 | 0.189 | 0.211 | 0.148 | 0.264 | 0.129 | 0.207 | 0.153 | 0.142 | 0.142 | 0.172 | 0.172 | 0.172 | 0.172 |
Total Other Income Expenses Net
| -31.43 | -47.445 | -2.488 | -9.359 | -12.822 | -12.865 | -7.713 | -15.7 | -25.754 | -6.022 | -27.218 | -32.131 | -11.394 | -12.091 | -1.905 | -0.363 | -2.16 | 0.365 | 0.365 | 14.346 | 14.346 | 14.346 | 14.346 |
Income Before Tax
| 135.723 | 118.528 | 164.529 | 178.786 | 131.195 | 104.006 | 94.971 | 131.125 | 105.702 | 157.156 | 127.211 | 152.393 | 98.83 | 144.823 | 76.423 | 104.556 | 78.441 | 34.034 | 34.034 | 54.237 | 54.237 | 54.237 | 54.237 |
Income Before Tax Ratio
| 0.18 | 0.166 | 0.17 | 0.219 | 0.155 | 0.139 | 0.127 | 0.189 | 0.151 | 0.18 | 0.156 | 0.189 | 0.133 | 0.213 | 0.133 | 0.185 | 0.151 | 0.144 | 0.144 | 0.234 | 0.234 | 0.234 | 0.234 |
Income Tax Expense
| 22.835 | 21.579 | 27.146 | 29.4 | 24.681 | 19.047 | 18.901 | 15.363 | 17.823 | 28.202 | 23.835 | 30.561 | 15.762 | 22.853 | 17.133 | 18.313 | 12.022 | 5.539 | 5.539 | 8.062 | 8.062 | 8.062 | 8.062 |
Net Income
| 112.928 | 125.823 | 114.852 | 136.192 | 97.627 | 80.039 | 71.2 | 102.513 | 88.413 | 127.218 | 97.531 | 121.941 | 80.329 | 122.276 | 57.052 | 84.47 | 61.14 | 25.476 | 25.476 | 43.089 | 43.089 | 43.089 | 43.089 |
Net Income Ratio
| 0.15 | 0.176 | 0.119 | 0.167 | 0.116 | 0.107 | 0.095 | 0.147 | 0.126 | 0.146 | 0.119 | 0.151 | 0.108 | 0.18 | 0.099 | 0.149 | 0.118 | 0.108 | 0.108 | 0.186 | 0.186 | 0.186 | 0.186 |
EPS
| 0.059 | 0.066 | 0.06 | 0.071 | 0.051 | 0.042 | 0.037 | 0.054 | 0.046 | 0.063 | 0.053 | 0.067 | 0.044 | 0.068 | 0.043 | 0.065 | 0.047 | 0.015 | 0.015 | 0.025 | 0.025 | 0.025 | 0.025 |
EPS Diluted
| 0.059 | 0.066 | 0.06 | 0.071 | 0.051 | 0.042 | 0.037 | 0.054 | 0.046 | 0.063 | 0.053 | 0.067 | 0.044 | 0.068 | 0.043 | 0.065 | 0.047 | 0.015 | 0.015 | 0.025 | 0.025 | 0.025 | 0.025 |
EBITDA
| 248.122 | 200.229 | 301.469 | 293.751 | 239.032 | 214.453 | 212.164 | 235.777 | 210.63 | 254.307 | 218.249 | 240.552 | 166.254 | 206.387 | 106.942 | 154.173 | 109.153 | 44.928 | 44.928 | 63.642 | 63.642 | 63.642 | 63.642 |
EBITDA Ratio
| 0.33 | 0.294 | 0.267 | 0.299 | 0.269 | 0.25 | 0.274 | 0.247 | 0.302 | 0.286 | 0.261 | 0.277 | 0.224 | 0.333 | 0.186 | 0.273 | 0.211 | 0.19 | 0.19 | 0.275 | 0.275 | 0.275 | 0.275 |